Trypanosoma cruzi Reactivation After Chimeric Antigen Receptor T-Cell Therapy

被引：0
|
作者：
Alahmdi, Bayan [1 ]
Kaur, Avneet [2 ]
Jacobs, Samantha E. [3 ]
Sullivan, Timothy [3 ]
Barghash, Maya [4 ]
Taimur, Sarah [3 ]
机构：
[1] King Abdulaziz Univ, Dept Med, Div Infect Dis, Jeddah, Saudi Arabia
[2] City Hope Natl Med Ctr, Dept Med, Div Infect Dis, Duarte, CA USA
[3] Icahn Sch Med Mt Sinai, Div Infect Dis, 1 Gustave L Levy Pl, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Cardiol, New York, NY 10029 USA
来源：
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 01期
关键词：
chimeric antigen receptor T-cell therapy; diffuse large B-cell lymphoma; hematopoietic cell transplant; Trypanosoma cruzi; CHAGAS-DISEASE; INFECTIOUS COMPLICATIONS; BENZNIDAZOLE; PATIENT;
D O I：
10.1093/ofid/ofad698
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
https://tidbitapp.io/tidbits/trypanosoma-cruzi-reactivation-post-chimeric-antigen-receptor-t-cell-therapy/update
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Perception of prognosis, quality of life, and distress in patients receiving chimeric antigen receptor T-cell therapy
    Dhawale, Tejaswini M.
    Johnson, P. Connor
    Gaballa, Mahmoud R.
    Nelson, Ashley M.
    Lavoie, Mitchell W.
    Boateng, Kofi Y.
    Greydanus, Claire
    Frigault, Matthew J.
    El-Jawahri, Areej
    CANCER, 2023, 129 (03) : 441 - 449
  • [42] Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options
    Toro-Mijares, Raul Del
    Oluwole, Olalekan
    Jayani, Reena V.
    Kassim, Adetola A.
    Savani, Bipin N.
    Dholaria, Bhagirathbhai
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (01) : 15 - 24
  • [43] Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy
    Wang, Xin Shelley
    Srour, Samer A.
    Mendoza, Tito
    Whisenant, Meagan
    Subbiah, Ishwaria
    Gonzalez, Elizabeth
    Kamal, Mona
    Shen, Shu-En
    Cleeland, Charles
    Kebriaei, Partow
    Rezvani, Katayoun
    Neelapu, Sattva
    Ahmed, Sairah
    Shpall, Elizabeth
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : 738 - 746
  • [44] Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes
    Khawaja, Fareed
    Ahmed, Sairah
    Iyer, Swaminathan P.
    Sassine, Joseph
    Handley, Guy
    Prakash, Rishab
    Vanwierren, Tracy
    Jackson, Jennifer
    Zubovskaia, Anna
    Ramdial, Jeremy
    Rondon, Gabriela
    Patel, Krina K.
    Spallone, Amy
    Ariza-Heredia, Ella J.
    Mulanovich, Victor
    Angelidakis, Georgios
    Jiang, Ying
    Chemaly, Roy F.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
  • [45] Early versus late infectious complications following chimeric antigen receptor-modified T-cell therapy
    Bindal, P.
    Trottier, C. A.
    Elavalakanar, P.
    Dodge, L. E.
    Kim, S.
    Logan, E.
    Ma, S.
    Liegel, J.
    Arnason, J.
    Alonso, C. D.
    LEUKEMIA & LYMPHOMA, 2025, 66 (04) : 702 - 712
  • [46] Prolonged Responses in Central Nervous System Relapsed Diffuse Large B-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy Using Targeted Treatments
    Planken, Simon
    Faict, Sylvia
    Trullemans, Fabienne
    Linskens, Eleni
    Vandepoele, Karl
    De Becker, Ann
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [47] Chimeric antigen receptor T-cell (CAR-T) therapy in patients with aggressive B-cell lymphomas. Current outlook after a decade of treatment
    Catala, Eva
    Iacoboni, Gloria
    Barba, Pere
    MEDICINA CLINICA, 2022, 158 (07): : 327 - 332
  • [48] Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma
    Padda, Jaskamal
    Khalid, Khizer
    Zubair, Ujala
    Peethala, Mounika M.
    Kakani, Varsha
    Goriparthi, Lakshmi
    Almanie, Abdulelah H.
    Cooper, Ayden Charlene
    Jean-Charles, Gutteridge
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [49] Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors
    Jindal, Vishal
    Arora, Ena
    Gupta, Sorab
    MEDICAL ONCOLOGY, 2018, 35 (06)
  • [50] Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors
    Vishal Jindal
    Ena Arora
    Sorab Gupta
    Medical Oncology, 2018, 35
12345